|
1
|
Puppa G, Sonzogni A, Colombari R and
Pelosi G: TNM staging system of colorectal carcinoma: A critical
appraisal of challenging issues. Arch Pathol Lab Med. 134:837–852.
2010.PubMed/NCBI
|
|
2
|
Hsu CC, Tseng LM and Lee HC: Role of
mitochondrial dysfunction in cancer progression. Exp Biol Med.
241:1281–1295. 2016. View Article : Google Scholar
|
|
3
|
Fearon ER: Molecular genetics of
colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Warburg O, Wind F and Negelein E: The
metabolism of tumors in the body. J Gen Physiol. 8:519–530. 1927.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim JW and Dang CV: Cancer's molecular
sweet tooth and the Warburg effect. Cancer Res. 66:8927–8930. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bratic I and Trifunovic A: Mitochondrial
energy metabolism and ageing. Biochim Biophys Acta. 797:961–967.
2010. View Article : Google Scholar
|
|
8
|
Gilkerson R, Bravo L, Garcia I, Gaytan N,
Herrera A, Maldonado A and Quintanilla B: The mitochondrial
nucleoid: Integrating mitochondrial DNA into cellular homeostasis.
Cold Spring Harb Perspect Biol. 5:a0110802013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kaniak-Golik A and Skoneczna A:
Mitochondria-nucleus network for genome stability. Free Radic Biol
Med. 82:73–104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Baker MJ, Frazier AE, Gulbis JM and Ryan
MT: Mitochondrial protein-import machinery: Correlating structure
with function. Trends Cell Biol. 17:456–464. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee HC and Wei YH: Mitochondrial
biogenesis and mitochondrial DNA maintenance of mammalian cells
under oxidative stress. Int J Biochem Cell Biol. 37:822–834. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Asin-Cayuela J and Gustafsson CM:
Mitochondrial transcription and its regulation in mammalian cells.
Trends Biochem Sci. 32:111–117. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moraes CT: What regulates mitochondrial
DNA copy number in animal cells? Trends Genet. 17:199–205. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boland ML, Chourasia AH and Macleod KF:
Mitochondrial dysfunction in cancer. Front Oncol. 3:2922013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin CS and Wang LS: Mitochondrial DNA
instability in human cancers. Formos J Surg. 46:71–75. 2013.
View Article : Google Scholar
|
|
16
|
Lee CH and Yu HS: Role of mitochondria,
ROS, and DNA damage in arsenic induced carcinogenesis. Front
Biosci. 8:312–320. 2016. View
Article : Google Scholar
|
|
17
|
Lee CH, Wu SB, Hong CH, Liao WT, Wu CY,
Chen GS, Wei YH and Yu HS: Aberrant cell proliferation by enhanced
mitochondrial biogenesis via mtTFA in arsenical skin cancers. Am J
Pathol. 178:2066–2076. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim MM, Clinger JD, Masayesva BG, Ha PK,
Zahurak ML, Westra WH and Califano JA: Mitochondrial DNA quantity
increases with histopathologic grade in premalignant and malignant
head and neck lesions. Clin Cancer Res. 10:8512–8515. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu M, Shi Y, Wei X, Yang Y, Zhou Y, Hao X,
Zhang N and Niu R: Depletion of mitochondrial DNA by ethidium
bromide treatment inhibits the proliferation and tumorigenesis of
T47D human breast cancer cells. Toxicol Lett. 170:83–93. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin CS, Chang SC, Ou LH, Chen CM, Hsieh
SS, Chung YP, King KL, Lin SL and Wei YH: Mitochondrial DNA
alterations correlate with the pathological status and the
immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast
invasive ductal carcinoma. Oncol Rep. 33:2924–2934. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin CS, Chang SC, Wang LS, Chou TY, Hsu
WH, Wu YC and Wei YH: The role of mitochondrial DNA alterations in
esophageal squamous cell carcinomas. J Thorac Cardiovasc Surg.
139:189–197 e184. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin CS, Lee HT, Lee SY, Shen YA, Wang LS,
Chen YJ and Wei YH: High mitochondrial DNA copy number and
bioenergetic function are associated with tumor invasion of
esophageal squamous cell carcinoma cell lines. Int J Mol Sci.
13:11228–11246. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee HC and Wei YH: Mitochondrial DNA
instability and metabolic shift in human cancers. Int J Mol Sci.
10:674–701. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roberts ER and Thomas KJ: The role of
mitochondria in the development and progression of lung cancer.
Comput Struct Biotechnol J. 6:e2013030192013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin CS, Wang LS, Tsai CM and Wei YH: Low
copy number and low oxidative damage of mitochondrial DNA are
associated with tumor progression in lung cancer tissues after
neoadjuvant chemotherapy. Interact Cardiovasc Thorac Surg.
7:954–958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Simonnet H, Alazard N, Pfeiffer K, Gallou
C, Béroud C, Demont J, Bouvier R, Schägger H and Godinot C: Low
mitochondrial respiratory chain content correlates with tumor
aggressiveness in renal cell carcinoma. Carcinogenesis. 23:759–768.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin CS, Lee HT, Lee MH, Pan SC, Ke CY,
Chiu AW and Wei YH: Role of mitochondrial DNA copy number
alteration in human renal cell carcinoma. Int J Mol Sci.
17:E8142016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu CW, Yin PH, Hung WY, Li AF, Li SH, Chi
CW, Wei YH and Lee HC: Mitochondrial DNA mutations and
mitochondrial DNA depletion in gastric cancer. Genes Chromosomes
Cancer. 44:19–28. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee YK, Woo HG and Yoon G: Mitochondrial
defect-responsive gene signature in liver-cancer progression. BMB
Rep. 48:597–598. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yin PH, Lee HC, Chau GY, Wu YT, Li SH, Lui
WY, Wei YH, Liu TY and Chi CW: Alteration of the copy number and
deletion of mitochondrial DNA in human hepatocellular carcinoma. Br
J Cancer. 90:2390–2396. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Toki N, Kagami S, Kurita T, Kawagoe T,
Matsuura Y, Hachisuga T, Matsuyama A, Hashimoto H, Izumi H and
Kohno K: Expression of mitochondrial transcription factor A in
endometrial carcinomas: Clinicopathologic correlations and
prognostic significance. Virchows Arch. 456:387–393. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Singh KP, Kumari R, Treas J and DuMond JW:
Chronic exposure to arsenic causes increased cell survival, DNA
damage, and increased expression of mitochondrial transcription
factor A (mtTFA) in human prostate epithelial cells. Chem Res
Toxicol. 24:340–349. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mo M, Peng F, Wang L, Peng L, Lan G and Yu
S: Roles of mitochondrial transcription factor A and
microRNA-590-3p in the development of bladder cancer. Oncol Lett.
6:617–623. 2013.PubMed/NCBI
|
|
34
|
Hewitt RE, McMarlin A, Kleiner D, Wersto
R, Martin P, Tsokos M, Stamp GW and Stetler-Stevenson WG:
Validation of a model of colon cancer progression. J Pathol.
192:446–454. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Leibovitz A, Stinson JC, McCombs WB III,
McCoy CE, Mazur KC and Mabry ND: Classification of human colorectal
adenocarcinoma cell lines. Cancer Res. 36:4562–4569.
1976.PubMed/NCBI
|
|
36
|
Futschik M, Jeffs A, Pattison S, Kasabov
N, Sullivan M, Merrie A and Reeve A: Gene expression profiling of
metastatic and nonmetastatic colorectal cancer cell lines. Genome
Lett. 1:26–34. 2002. View Article : Google Scholar
|
|
37
|
Lee CC, Chen WS, Chen CC, Chen LL, Lin YS,
Fan CS and Huang TS: TCF12 protein functions as transcriptional
repressor of E-cadherin, and its overexpression is correlated with
metastasis of colorectal cancer. J Biol Chem. 287:2798–2809. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang CH, Wang CC, Huang HC and Wei YH:
Mitochondrial dysfunction leads to impairment of insulin
sensitivity and adiponectin secretion in adipocytes. FEBS J.
280:1039–1050. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma J, Zhang Q, Chen S, Fang B, Yang Q,
Chen C, Miele L, Sarkar FH, Xia J and Wang Z: Mitochondrial
dysfunction promotes breast cancer cell migration and invasion
through HIF1α accumulation via increased production of reactive
oxygen species. PLoS One. 8:e694852013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cillero-Pastor B, Rego-Pérez I, Oreiro N,
Fernandez-Lopez C and Blanco FJ: Mitochondrial respiratory chain
dysfunction modulates metalloproteases −1, −3 and −13 in human
normal chondrocytes in culture. BMC Musculoskelet Disord.
14:2352013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li C, Wu Z, Liu M, Pazgier M and Lu W:
Chemically synthesized human survivin does not inhibit caspase-3.
Protein Sci. 17:1624–1629. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Salazar N, Muñoz D, Hoy J and Lokeshwar
BL: Use of shRNA for stable suppression of chemokine receptor
expression and function in human cancer cell lines. Methods Mol
Biol. 1172:209–218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen CT, Shih YR, Kuo TK, Lee OK and Wei
YH: Coordinated changes of mitochondrial biogenesis and antioxidant
enzymes during osteogenic differentiation of human mesenchymal stem
cells. Stem Cells. 26:960–968. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Clerc P and Polster BM: Investigation of
mitochondrial dysfunction by sequential microplate-based
respiration measurements from intact and permeabilized neurons.
PLoS One. 7:e344652012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang CH, Chen YF, Wu CY, Wu PC, Huang YL,
Kao CH, Lin CH, Kao LS, Tsai TF and Wei YH: Cisd2 modulates the
differentiation and functioning of adipocytes by regulating
intracellular Ca2+ homeostasis. Hum Mol Genet.
23:4770–4785. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chou SJ, Tseng WL, Chen CT, Lai YF, Chien
CS, Chang YL, Lee HC, Wei YH and Chiou SH: Impaired ROS scavenging
system in human induced pluripotent stem cells generated from
patients with MERRF syndrome. Sci Rep. 6:236612016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lee HT, Lin CS, Chen WS, Liao HT, Tsai CY
and Wei YH: Leukocyte mitochondrial DNA alteration in systemic
lupus erythematosus and its relevance to the susceptibility to
lupus nephritis. Int J Mol Sci. 13:8853–8868. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lee HT, Lin CS, Lee CS, Tsai CY and Wei
YH: Increased 8-hydroxy-2′-deoxyguanosine in plasma and decreased
mRNA expression of human 8-oxoguanine DNA glycosylase 1,
anti-oxidant enzymes, mitochondrial biogenesis-related proteins and
glycolytic enzymes in leucocytes in patients with systemic lupus
erythematosus. Clin Exp Immunol. 176:66–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kubens BS and Zänker KS: Differences in
the migration capacity of primary human colon carcinoma cells
(SW480) and their lymph node metastatic derivatives (SW620). Cancer
Lett. 131:55–64. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Koppenol WH, Bounds PL and Dang CV: Otto
Warburg's contributions to current concepts of cancer metabolism.
Nat Rev Cancer. 11:325–337. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pedersen PL: Warburg, me and Hexokinase 2:
Multiple discoveries of key molecular events underlying one of
cancers' most common phenotypes, the ‘Warburg Effect’, i.e.,
elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr.
39:211–222. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gatenby RA and Gillies RJ: Why do cancers
have high aerobic glycolysis? Nat Rev Cancer. 4:891–899. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lu J, Tan M and Cai Q: The Warburg effect
in tumor progression: Mitochondrial oxidative metabolism as an
anti-metastasis mechanism. Cancer Lett. 356:156–164. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zong WX, Rabinowitz JD and White E:
Mitochondria and Cancer. Mol Cell. 61:667–676. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Verschoor ML, Ungard R, Harbottle A,
Jakupciak JP, Parr RL and Singh G: Mitochondria and cancer: Past,
present, and future. Biomed Res Int. 2013:6123692013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lee HC, Yin PH, Lin JC, Wu CC, Chen CY, Wu
CW, Chi CW, Tam TN and Wei YH: Mitochondrial genome instability and
mtDNA depletion in human cancers. Ann NY Acad Sci. 1042:109–122.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Tseng LM, Yin PH, Chi CW, Hsu CY, Wu CW,
Lee LM, Wei YH and Lee HC: Mitochondrial DNA mutations and
mitochondrial DNA depletion in breast cancer. Genes Chromosomes
Cancer. 45:629–638. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Jiang WW, Masayesva B, Zahurak M, Carvalho
AL, Rosenbaum E, Mambo E, Zhou S, Minhas K, Benoit N, Westra WH, et
al: Increased mitochondrial DNA content in saliva associated with
head and neck cancer. Clin Cancer Res. 11:2486–2491. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wen S, Gao J, Zhang L, Zhou H, Fang D and
Feng S: p53 increase mitochondrial copy number via up-regulation of
mitochondrial transcription factor A in colorectal cancer.
Oncotarget. 7:75981–75995. 2016.PubMed/NCBI
|
|
61
|
Gao J, Wen S, Zhou H and Feng S:
De-methylation of displacement loop of mitochondrial DNA is
associated with increased mitochondrial copy number and
nicotinamide adenine dinucleotide subunit 2 expression in
colorectal cancer. Mol Med Rep. 12:7033–7038. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Feng S, Xiong L, Ji Z, Cheng W and Yang H:
Correlation between increased copy number of mitochondrial DNA and
clinicopathological stage in colorectal cancer. Oncol Lett.
2:899–903. 2011.PubMed/NCBI
|
|
63
|
Feng S, Xiong L, Ji Z, Cheng W and Yang H:
Correlation between increased ND2 expression and demethylated
displacement loop of mtDNA in colorectal cancer. Mol Med Rep.
6:125–130. 2012.PubMed/NCBI
|
|
64
|
van Osch FH, Voets AM, Schouten LJ,
Gottschalk RW, Simons CC, van Engeland M, Lentjes MH, van den
Brandt PA, Smeets HJ and Weijenberg MP: Mitochondrial DNA copy
number in colorectal cancer: Between tissue comparisons,
clinicopathological characteristics and survival. Carcinogenesis.
36:1502–1510. 2015.PubMed/NCBI
|
|
65
|
Cui H, Huang P, Wang Z, Zhang Y, Zhang Z,
Xu W, Wang X, Han Y and Guo X: Association of decreased
mitochondrial DNA content with the progression of colorectal
cancer. BMC Cancer. 13:1102013. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Sanchez-Pino MJ, Moreno P and Navarro A:
Mitochondrial dysfunction in human colorectal cancer progression.
Front Biosci. 12:1190–1199. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
67
|
Phan LM, Yeung SC and Lee MH: Cancer
metabolic reprogramming: Importance, main features, and potentials
for precise targeted anti-cancer therapies. Cancer Biol Med.
11:1–19. 2014.PubMed/NCBI
|
|
68
|
Yoshida GJ: Metabolic reprogramming: The
emerging concept and associated therapeutic strategies. J Exp Clin
Cancer Res. 34:1112015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ward PS and Thompson CB: Metabolic
reprogramming: A cancer hallmark even warburg did not anticipate.
Cancer Cell. 21:297–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Koukourakis MI, Giatromanolaki A, Sivridis
E, Gatter KC and Harris AL; Tumor and Angiogenesis Research Group,
: Pyruvate dehydrogenase and pyruvate dehydrogenase kinase
expression in non small cell lung cancer and tumor-associated
stroma. Neoplasia. 7:1–6. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zheng J: Energy metabolism of cancer:
Glycolysis versus oxidative phosphorylation (Review). Oncol Lett.
4:1151–1157. 2012.PubMed/NCBI
|
|
72
|
Vyas S, Zaganjor E and Haigis MC:
Mitochondria and cancer. Cell. 166:555–566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Ahn CS and Metallo CM: Mitochondria as
biosynthetic factories for cancer proliferation. Cancer Metab.
3:12015. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Shen YA, Wang CY, Hsieh YT, Chen YJ and
Wei YH: Metabolic reprogramming orchestrates cancer stem cell
properties in nasopharyngeal carcinoma. Cell Cycle. 14:86–98. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Shen YA, Lin CH, Chi WH, Wang CY, Hsieh
YT, Wei YH and Chen YJ: Resveratrol impedes the stemness,
epithelial-mesenchymal transition, and metabolic reprogramming of
cancer stem cells in nasopharyngeal carcinoma through p53
activation. Evid Based Complement Alternat Med. 2013:5903932013.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Guha M, Srinivasan S, Ruthel G, Kashina
AK, Carstens RP, Mendoza A, Khanna C, Van Winkle T and Avadhani NG:
Mitochondrial retrograde signaling induces epithelial-mesenchymal
transition and generates breast cancer stem cells. Oncogene.
33:5238–5250. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Chang CJ, Yin PH, Yang DM, Wang CH, Hung
WY, Chi CW, Wei YH and Lee HC: Mitochondrial dysfunction-induced
amphiregulin upregulation mediates chemo-resistance and cell
migration in HepG2 cells. Cell Mol Life Sci. 66:1755–1765. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yoshida Y, Hasegawa J, Nezu R, Kim YK,
Hirota M, Kawano K, Izumi H and Kohno K: Clinical usefulness of
mitochondrial transcription factor A expression as a predictive
marker in colorectal cancer patients treated with FOLFOX. Cancer
Sci. 102:578–582. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Nakayama Y, Yamauchi M, Minagawa N,
Torigoe T, Izumi H, Kohno K and Yamaguchi K: Clinical significance
of mitochondrial transcription factor A expression in patients with
colorectal cancer. Oncol Rep. 27:1325–1330. 2012.PubMed/NCBI
|
|
80
|
Barbour JA and Turner N: Mitochondrial
stress signaling promotes cellular adaptations. Int J Cell Biol.
2014:1560202014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
da Cunha FM, Torelli NQ and Kowaltowski
AJ: Mitochondrial retrograde signaling: Triggers, pathways, and
outcomes. Oxid Med Cell Longev. 2015:4825822015. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Guha M and Avadhani NG: Mitochondrial
retrograde signaling at the crossroads of tumor bioenergetics,
genetics and epigenetics. Mitochondrion. 13:577–591. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Murphy MP: How mitochondria produce
reactive oxygen species. Biochem J. 417:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
St-Pierre J, Drori S, Uldry M, Silvaggi
JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, et al:
Suppression of reactive oxygen species and neurodegeneration by the
PGC-1 transcriptional coactivators. Cell. 127:397–408. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Dröge W: Free radicals in the
physiological control of cell function. Physiol Rev. 82:47–95.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Alfadda AA and Sallam RM: Reactive oxygen
species in health and disease. J Biomed Biotechnol.
2012:9364862012. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Eisele HJ, Markart P and Schulz R:
Obstructive sleep apnea, oxidative stress, and cardiovascular
disease: Evidence from human studies. Oxid Med Cell Longev.
2015:6084382015. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Sabharwal SS and Schumacker PT:
Mitochondrial ROS in cancer: Initiators, amplifiers or an Achilles'
heel? Nat Rev Cancer. 14:709–721. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Lu F: Reactive oxygen species in cancer,
too much or too little? Med Hypotheses. 69:1293–1298. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kondoh H, Lleonart ME, Gil J, Wang J,
Degan P, Peters G, Martinez D, Carnero A and Beach D: Glycolytic
enzymes can modulate cellular life span. Cancer Res. 65:177–185.
2005.PubMed/NCBI
|
|
91
|
Li F, Wang Y, Zeller KI, Potter JJ, Wonsey
DR, O'Donnell KA, Kim JW, Yustein JT, Lee LA and Dang CV: Myc
stimulates nuclearly encoded mitochondrial genes and mitochondrial
biogenesis. Mol Cell Biol. 25:6225–6234. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Papandreou I, Cairns RA, Fontana L, Lim AL
and Denko NC: HIF-1 mediates adaptation to hypoxia by actively
downregulating mitochondrial oxygen consumption. Cell Metab.
3:187–197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Buzzai M, Bauer DE, Jones RG, Deberardinis
RJ, Hatzivassiliou G, Elstrom RL and Thompson CB: The glucose
dependence of Akt-transformed cells can be reversed by
pharmacologic activation of fatty acid beta-oxidation. Oncogene.
24:4165–4173. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Düvel K, Yecies JL, Menon S, Raman P,
Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S,
et al: Activation of a metabolic gene regulatory network downstream
of mTOR complex 1. Mol Cell. 39:171–183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Fields J, Hanisch JJ, Choi JW and Hwang
PM: How does p53 regulate mitochondrial respiration? IUBMB Life.
59:682–684. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Ni J, Jiang Z, Shen L, Gao L, Yu M, Xu X,
Zou S, Hua D and Wu S: β3GnT8 regulates the metastatic potential of
colorectal carcinoma cells by altering the glycosylation of CD147.
Oncol Rep. 31:1795–1801. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Cai K, Mulatz K, Ard R, Nguyen T and Gee
SH: Increased diacylglycerol kinase ζ expression in human
metastatic colon cancer cells augments Rho GTPase activity and
contributes to enhanced invasion. BMC Cancer. 14:2082014.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Schimanski CC, Schwald S, Simiantonaki N,
Jayasinghe C, Gönner U, Wilsberg V, Junginger T, Berger MR, Galle
PR and Moehler M: Effect of chemokine receptors CXCR4 and CCR7 on
the metastatic behavior of human colorectal cancer. Clin Cancer
Res. 11:1743–1750. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Kusakai G, Suzuki A, Ogura T, Miyamoto S,
Ochiai A, Kaminishi M and Esumi H: ARK5 expression in colorectal
cancer and its implications for tumor progression. Am J Pathol.
164:987–995. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Friedl P and Alexander S: Cancer invasion
and the microenvironment: Plasticity and reciprocity. Cell.
147:992–1009. 2011. View Article : Google Scholar : PubMed/NCBI
|
